Your browser doesn't support javascript.
loading
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination.
Mühlenbruch, Lena; Abou-Kors, Tsima; Dubbelaar, Marissa L; Bichmann, Leon; Kohlbacher, Oliver; Bens, Martin; Thomas, Jaya; Ezic, Jasmin; Kraus, Johann M; Kestler, Hans A; von Witzleben, Adrian; Mytilineos, Joannis; Fürst, Daniel; Engelhardt, Daphne; Doescher, Johannes; Greve, Jens; Schuler, Patrick J; Theodoraki, Marie-Nicole; Brunner, Cornelia; Hoffmann, Thomas K; Rammensee, Hans-Georg; Walz, Juliane S; Laban, Simon.
  • Mühlenbruch L; Institute for Cell Biology, Department of Immunology, Eberhard Karls University of Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Abou-Kors T; Department of Peptide-based Immunotherapy, Eberhard Karls University and University Hospital Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Dubbelaar ML; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Bichmann L; German Cancer Consortium (DKTK), Partner Site Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Kohlbacher O; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Head and Neck Cancer Center of the Comprehensive Cancer Center Ulm, Ulm, Germany.
  • Bens M; Institute for Cell Biology, Department of Immunology, Eberhard Karls University of Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Thomas J; Department of Peptide-based Immunotherapy, Eberhard Karls University and University Hospital Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Ezic J; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Kraus JM; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Kestler HA; Institute for Cell Biology, Department of Immunology, Eberhard Karls University of Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • von Witzleben A; Applied Bioinformatics, Department of Computer Science, Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Mytilineos J; Applied Bioinformatics, Department of Computer Science, Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Fürst D; Cluster of Excellence Machine Learning in the Sciences (EXC2064), Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Engelhardt D; Institute for Translational Bioinformatics, University Hospital Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Doescher J; Institute for Bioinformatics and Medical Informatics, Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.
  • Greve J; Leibniz-Institute on Aging, Fritz-Lipmann-Institute, 07745, Jena, Thüringen, Germany.
  • Schuler PJ; CRUK and NIHR Experimental Cancer Medicine Center & School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK.
  • Theodoraki MN; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Head and Neck Cancer Center of the Comprehensive Cancer Center Ulm, Ulm, Germany.
  • Brunner C; Ulm University, Institute of Medical Systems Biology, Ulm, Germany.
  • Hoffmann TK; Ulm University, Institute of Medical Systems Biology, Ulm, Germany.
  • Rammensee HG; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Head and Neck Cancer Center of the Comprehensive Cancer Center Ulm, Ulm, Germany.
  • Walz JS; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
  • Laban S; Institute of Transfusion Medicine, Ulm University, Ulm, Germany.
Br J Cancer ; 128(9): 1777-1787, 2023 05.
Article en En | MEDLINE | ID: mdl-36823366
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de Oído, Nariz y Garganta / Infecciones por Papillomavirus / Carcinoma de Células Escamosas de Cabeza y Cuello / Antígenos HLA Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de Oído, Nariz y Garganta / Infecciones por Papillomavirus / Carcinoma de Células Escamosas de Cabeza y Cuello / Antígenos HLA Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article